UBM India has announced the jury panel for the second edition of its India Pharma Awards. Recognizing leading innovators across nine categories, the UBM India Pharma Awards acknowledge innovation and excellence in the Indian pharma industry, thus creating an industry platform to celebrate the contribution of the key players amongst their Indian and international fraternity.

Against the backdrop of the global pharma industry increasingly looking at India for higher quality and low cost pharma solutions, the India Pharma Awards celebrate the thinkers and creators who consistently break new ground in the pharma sector thereby taking the value chain to its next level.

UBM India has on board, distinguished and renowned jury members from the industry. The jury panel for 2014 India Pharma Awards will be chaired by Dr. Sudarshan Jain, managing director, Abbott Healthcare Solutions, Dr Ajit Dangi, president and CEO, Danssen Consulting, Dr Safia Rizvi, managing director, UCB India Private Ltd,  Devinder Pal, president, Catalyst Pharma Consulting and S V Veerramani, founder & chairman, Fourrts (India) & president, IDMA.

Says Joji George, managing director, UBM India “The consent of such an esteemed panel to be associated with the awards, further validates the industry need and acceptance of such a platform in India, to acknowledge and recognize the contribution of pharma companies.”

The second annual India Pharma Awards is slated for December 1, 2014 at The Westin Garden City, Mumbai. The event which will be attended by more than 300 decision makers from across the industry. India's pharma machinery, technology, ingredients, outsourcing and biopharma industry, will also witness participation of key officials from the ministries (home, food & drug dept).

For more details: www.ubmindia.in/indiapharma-awards. And for further information on partnering opportunities contact: Jayesh Kanaskar on +91-22-61727173.